A detailed history of Susquehanna International Group, LLP transactions in Oramed Pharmaceuticals Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 134,373 shares of ORMP stock, worth $318,464. This represents 0.0% of its overall portfolio holdings.

Number of Shares
134,373
Previous 125,828 6.79%
Holding current value
$318,464
Previous $323,000 1.24%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$2.21 - $2.63 $18,884 - $22,473
8,545 Added 6.79%
134,373 $327,000
Q2 2024

Aug 15, 2024

SELL
$2.07 - $2.83 $452,522 - $618,666
-218,610 Reduced 63.47%
125,828 $323,000
Q1 2024

May 07, 2024

BUY
$2.18 - $3.58 $650,777 - $1.07 Million
298,522 Added 650.15%
344,438 $1.01 Million
Q4 2023

Feb 14, 2024

BUY
$1.71 - $2.57 $56,170 - $84,419
32,848 Added 251.36%
45,916 $106,000
Q3 2023

Nov 14, 2023

SELL
$2.51 - $3.55 $186,831 - $264,244
-74,435 Reduced 85.07%
13,068 $34,000
Q2 2023

Aug 11, 2023

BUY
$2.12 - $4.47 $155,425 - $327,713
73,314 Added 516.7%
87,503 $313,000
Q1 2023

May 16, 2023

SELL
$1.93 - $13.1 $330,834 - $2.25 Million
-171,417 Reduced 92.36%
14,189 $30,000
Q4 2022

Feb 14, 2023

BUY
$5.88 - $12.03 $83,901 - $171,656
14,269 Added 8.33%
185,606 $2.23 Million
Q3 2022

Nov 14, 2022

BUY
$4.6 - $9.91 $297,615 - $641,167
64,699 Added 60.67%
171,337 $1.11 Million
Q2 2022

Aug 15, 2022

BUY
$3.72 - $9.0 $106,589 - $257,877
28,653 Added 36.74%
106,638 $488,000
Q1 2022

May 16, 2022

SELL
$8.19 - $13.89 $314,684 - $533,695
-38,423 Reduced 33.01%
77,985 $675,000
Q4 2021

Feb 14, 2022

BUY
$12.98 - $29.75 $1.3 Million - $2.97 Million
99,976 Added 608.42%
116,408 $1.66 Million
Q3 2021

Nov 15, 2021

BUY
$12.13 - $23.82 $53,735 - $105,522
4,430 Added 36.91%
16,432 $361,000
Q2 2021

Aug 11, 2021

SELL
$8.34 - $14.59 $469,567 - $821,460
-56,303 Reduced 82.43%
12,002 $161,000
Q1 2021

May 17, 2021

BUY
$4.22 - $11.33 $230,736 - $619,490
54,677 Added 401.21%
68,305 $694,000
Q4 2019

Feb 14, 2020

SELL
$2.43 - $5.74 $2,857 - $6,750
-1,176 Reduced 7.94%
13,628 $70,000
Q3 2019

Nov 14, 2019

BUY
$2.88 - $3.96 $42,635 - $58,623
14,804 New
14,804 $47,000
Q1 2018

May 15, 2018

SELL
$6.51 - $9.14 $120,265 - $168,852
-18,474 Closed
0 $0
Q4 2017

Feb 14, 2018

SELL
$7.95 - $11.15 $2,289 - $3,211
-288 Reduced 1.54%
18,474 $166,000
Q3 2017

Nov 14, 2017

BUY
$7.74 - $10.78 $145,217 - $202,254
18,762
18,762 $185,000

Others Institutions Holding ORMP

About ORAMED PHARMACEUTICALS INC.


  • Ticker ORMP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,827,100
  • Market Cap $92M
  • Description
  • Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...
More about ORMP
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.